BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34614192)

  • 1. DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasma.
    Zuccato JA; Patil V; Mansouri S; Liu JC; Nassiri F; Mamatjan Y; Chakravarthy A; Karimi S; Almeida JP; Bernat AL; Hasen M; Singh O; Khan S; Kislinger T; Sinha N; Froelich S; Adle-Biassette H; Aldape KD; De Carvalho DD; Zadeh G
    Neuro Oncol; 2022 Mar; 24(3):442-454. PubMed ID: 34614192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation, combined with RNA sequencing, provide novel insight into molecular classification of chordomas and their microenvironment.
    Baluszek S; Kober P; Rusetska N; Wągrodzki M; Mandat T; Kunicki J; Bujko M
    Acta Neuropathol Commun; 2023 Jul; 11(1):113. PubMed ID: 37434245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation-based reclassification and risk stratification of skull-base chordomas.
    Huo X; Guo T; Wang K; Yao B; Li D; Li H; Chen W; Wang L; Wu Z
    Front Oncol; 2022; 12():960005. PubMed ID: 36439461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide DNA methylation profiling of recurrent and non-recurrent chordomas.
    Alholle A; Brini AT; Bauer J; Gharanei S; Niada S; Slater A; Gentle D; Maher ER; Jeys L; Grimer R; Sumathi VP; Latif F
    Epigenetics; 2015; 10(3):213-20. PubMed ID: 25621392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of a Category Based on Electron Microscopic Features of Clival Chordomas.
    Bai J; Zhai Y; Wang S; Gao H; Du J; Wang J; Li M; Li C; Gui S; Zhang C; Sun Y; Zhang Y
    World Neurosurg; 2017 Mar; 99():282-287. PubMed ID: 27916725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pediatric SMARCB1/INI1-deficient poorly differentiated chordoma of the skull base: report of five cases and review of literature].
    Duan ZJ; Yao K; Ma Z; Hu ZJ; Xiang L; Qi XL
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):33-38. PubMed ID: 34979751
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
    Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
    Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome comparison identifies potential biomarkers of spine and skull base chordomas.
    Bell AH; DeMonte F; Raza SM; Rhines LD; Tatsui CE; Prieto VG; Fuller GN; Bell D
    Virchows Arch; 2018 Mar; 472(3):489-497. PubMed ID: 28844110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
    Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
    World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal profiling of chordoma immunity reveals distinct immune contextures.
    van Oost S; Meijer DM; Ijsselsteijn ME; Roelands JP; van den Akker BEMW; van der Breggen R; Briaire-de Bruijn IH; van der Ploeg M; Wijers-Koster PM; Polak SB; Peul WC; van der Wal RJP; de Miranda NFCC; Bovee JVMG
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38272563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.
    Pan Y; Lu L; Chen J; Zhong Y; Dai Z
    J Orthop Surg Res; 2018 Apr; 13(1):76. PubMed ID: 29625617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chordoma characterization of significant changes of the DNA methylation pattern.
    Rinner B; Weinhaeusel A; Lohberger B; Froehlich EV; Pulverer W; Fischer C; Meditz K; Scheipl S; Trajanoski S; Guelly C; Leithner A; Liegl B
    PLoS One; 2013; 8(3):e56609. PubMed ID: 23533570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chordoma: Immunohistochemical Analysis of Brachury.
    Sun HI; Guduk M; Gucyetmez B; Yapicier O; Pamir MN
    Turk Neurosurg; 2018; 28(2):174-178. PubMed ID: 28094431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival.
    Conway K; Edmiston SN; May R; Kuan PF; Chu H; Bryant C; Tse CK; Swift-Scanlan T; Geradts J; Troester MA; Millikan RC
    Breast Cancer Res; 2014 Oct; 16(5):450. PubMed ID: 25287138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chordoma: the entity.
    Yakkioui Y; van Overbeeke JJ; Santegoeds R; van Engeland M; Temel Y
    Biochim Biophys Acta; 2014 Dec; 1846(2):655-69. PubMed ID: 25193090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chordoma and chondroid neoplasms of the spheno-occiput. An immunohistochemical study of 41 cases with prognostic and nosologic implications.
    Mitchell A; Scheithauer BW; Unni KK; Forsyth PJ; Wold LE; McGivney DJ
    Cancer; 1993 Nov; 72(10):2943-9. PubMed ID: 7693324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma.
    Rosenberg AE; Nielsen GP; Keel SB; Renard LG; Fitzek MM; Munzenrider JE; Liebsch NJ
    Am J Surg Pathol; 1999 Nov; 23(11):1370-8. PubMed ID: 10555005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of ezrin, MMP-9, and COX-2 in 50 chordoma specimens: a clinical and immunohistochemical analysis.
    Froehlich EV; Scheipl S; Lazàry A; Varga PP; Schmid C; Stammberger H; Beham A; Bodo K; Schroettner H; Quehenberger F; Windhager R; Liegl B; Leithner A
    Spine (Phila Pa 1976); 2012 Jun; 37(13):E757-67. PubMed ID: 22228328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chordoma].
    George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
    Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 3p loss of heterozygosity and reduced expression of H3K36me3 correlate with longer relapse-free survival in sacral conventional chordoma.
    Zhu GG; Ramirez D; Chen W; Lu C; Wang L; Frosina D; Jungbluth A; Ntiamoah P; Nafa K; Boland PJ; Hameed MR
    Hum Pathol; 2020 Oct; 104():73-83. PubMed ID: 32795465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.